Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Open in API
Filings indexed 765 across all filing types
Latest filing 2024-12-02 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a detailed Next Day Disclosure Return (Form FF305) under the Hong Kong Stock Exchange Listing Rules, reporting on‐market repurchases of the company’s own shares (treasury shares). It provides share class, stock code, opening/closing balances, repurchase method, prices, volumes, and confirms compliance with listing rules. This constitutes a share buyback/own‐share transaction filing, matching the “Transaction in Own Shares” category.
2024-12-02 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a Next Day Disclosure Return under Hong Kong Listing Rules detailing changes in issued shares, repurchased treasury shares, and on-market sale of treasury shares, including specific transaction dates, prices, and share counts. This is a report of the company buying back its own shares. It fits the definition of a "Transaction in Own Shares" (POS) rather than a broader capital change or periodic report.
2024-11-29 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a statutory Hong Kong Exchange Next Day Disclosure Return (Form FF305) detailing changes in issued shares and treasury shares, specifically the on-market repurchase of 1,000,000 ordinary shares, including repurchase dates, prices, quantities, mandates and confirmations. This is not an announcement of an attached report but the full disclosure itself. It clearly falls under a company’s buyback of its own shares, which corresponds to Transaction in Own Shares (POS).
2024-11-28 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 1% confidence The document is a "Next Day Disclosure Return" (Form FF305) filed under Hong Kong Stock Exchange listing rules (Main Board Rule 13.25A/GEM Rule 17.27A) that provides detailed reporting of changes in issued shares and treasury shares, including on-market share repurchases and treasury share transactions. This is not a fundraising or financing announcement, not a dividend notice, not a governance or legal filing, but a mandatory regulatory disclosure of the company’s own share transactions (repurchases/holdings). Therefore, it falls squarely under the category Transaction in Own Shares (POS).
2024-11-27 English
Next Day Disclosure Return
Regulatory Filings
2024-11-25 English
Next Day Disclosure Return
Regulatory Filings
2024-11-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.